Centessa Pharmaceuticals plc
8-K
June 24, 2026
Key Highlights
- Successful acquisition of Centessa Pharmaceuticals by Eli Lilly
- Shareholders receive $38.00 per share in cash
- Potential for additional $9.00 per share via Contingent Value Rights (CVRs)
Read Analysis
π€ AI Generated